MedPath

DOJS HOLDINGS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

TGA:7

Drug Approvals

BergaMALE + (462928)

Product Name
BergaMALE +
Approval Date
Sep 26, 2024
TGA

BergaMet Max (457674)

Product Name
BergaMet Max
Approval Date
Jul 30, 2024
TGA

BergaMet Pro+ (408879)

Product Name
BergaMet Pro+
Approval Date
May 12, 2023
TGA

BergaMALE + (407479)

Product Name
BergaMALE +
Approval Date
Apr 11, 2023
TGA

BergaFEMME+ (389170)

Product Name
BergaFEMME+
Approval Date
May 26, 2022
TGA

BergaMet Advanced (375467)

Product Name
BergaMet Advanced
Approval Date
Sep 29, 2021
TGA

BergaMet (330272)

Product Name
BergaMet
Approval Date
Feb 21, 2020
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.